Gastrointestinal Motility Disorder
📧 Sign up to get email alerts when something new happens for Gastrointestinal Motility Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-24Clinical Trial Update: Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility [Phase 3]
A Phase 3 trial evaluating rifaximin for covert hepatic encephalopathy with SIBO and GI dysmotility was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Lanreotide in the Treatment of Small Bowel Motility Disorders [Phase 2]
Phase 2 trial evaluating lanreotide for small bowel motility disorders has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of intravenous TD-8954, a 5-HT4 receptor agonist, in healthy subjects; t…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water [Phase 1]
Phase 1 study assessing the absorption of paracetamol, talinolol, and amoxicillin after oral administration with non-caloric and caloric wat…
-
CLINICAL_TRIALS research · 2011-11-03Clinical Trial Update: Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants? [Phase 2]
This entry describes an ongoing Phase 2 trial evaluating SMOFlipid, a composite parenteral nutrition lipid emulsion, to prevent progression …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.